Top Buy
Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 67 | 0 | 13 | 0 | €852.40 | €883.50 | 3.649% |
Alnylam Pharmace. | 47 | 1 | 11 | 1 | €228.00 | €251.80 | 10.439% |
AbbVie Inc. | 35 | 0 | 9 | 0 | €158.50 | €175.98 | 11.027% |
Regeneron Pharmaceuticals Inc. | 47 | 1 | 7 | 0 | €978.00 | €1,046.4 | 6.989% |
Sarepta Therapeutics | 8 | 0 | 7 | 0 | €147.55 | €190.00 | 28.770% |
Vertex Pharmaceuticals Inc. | 52 | 2 | 3 | 0 | €441.05 | €432.21 | -2.005% |
Gilead Sciences Inc | 15 | 1 | 3 | 0 | €64.00 | €79.54 | 24.286% |
Intra-Cellular Therapies Inc. | 31 | 0 | 3 | 0 | €65.00 | €83.92 | 29.108% |
Pfizer Inc. | 32 | 4 | 3 | 0 | €26.04 | €40.66 | 56.142% |
Amgen Inc. | 28 | 0 | 3 | 0 | €292.85 | €300.61 | 2.649% |
Johnson & Johnson | 38 | 1 | 3 | 0 | €136.80 | €187.15 | 36.808% |
Biogen Inc. | 53 | 1 | 3 | 0 | €218.70 | €292.88 | 33.917% |
Acadia Pharmaceuticals | 30 | 1 | 2 | 0 | €15.30 | €31.00 | 102.703% |